Eastern Europe: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Eastern Europe

For the third year in a row, the East European medicaments containing insulin market recorded decline in sales value, which decreased by -25.4% to $X in 2021. In general, consumption continues to indicate a abrupt curtailment. Over the period under review, the market attained the peak level at $X in 2013; however, from 2014 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production in Eastern Europe

In value terms, medicaments containing insulin production reached $X in 2021 estimated in export price. Overall, production continues to indicate a mild downturn. The most prominent rate of growth was recorded in 2016 with an increase of 15% against the previous year. As a result, production attained the peak level of $X. From 2017 to 2021, production growth remained at a lower figure.

Medicaments Containing Insulin Exports

Exports in Eastern Europe

In 2021, medicaments containing insulin exports in Eastern Europe soared to X tons, growing by 18% against the year before. Over the period under review, exports, however, continue to indicate a sharp shrinkage. The growth pace was the most rapid in 2014 when exports increased by 64% against the previous year. The volume of export peaked at X tons in 2015; however, from 2016 to 2021, the exports remained at a lower figure.

In value terms, medicaments containing insulin exports amounted to $X in 2021. Overall, exports, however, continue to indicate a deep slump. The most prominent rate of growth was recorded in 2018 when exports increased by 65% against the previous year. Over the period under review, the exports hit record highs at $X in 2014; however, from 2015 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

In 2021, the Czech Republic (X tons) represented the key exporter of medicaments containing insulin but not antibiotics, achieving 53% of total exports. Slovakia (X kg) took a 30% share (based on physical terms) of total exports, which put it in second place, followed by Romania (9.1%) and Russia (7%).

From 2012 to 2021, the most notable rate of growth in terms of shipments, amongst the key exporting countries, was attained by Romania (with a CAGR of +23.4%), while the other leaders experienced more modest paces of growth.

In value terms, the Czech Republic ($X) remains the largest medicaments containing insulin supplier in Eastern Europe, comprising 68% of total exports. The second position in the ranking was held by Romania ($X), with a 22% share of total exports. It was followed by Slovakia, with a 6.1% share.

In the Czech Republic, medicaments containing insulin exports increased at an average annual rate of +12.5% over the period from 2012-2021. In the other countries, the average annual rates were as follows: Romania (+38.8% per year) and Slovakia (-21.6% per year).

Export Prices by Country

In 2021, the export price in Eastern Europe amounted to $X per ton, with a decrease of -9% against the previous year. Over the period under review, the export price, however, saw a buoyant increase. The most prominent rate of growth was recorded in 2016 when the export price increased by 141% against the previous year. Over the period under review, the export prices hit record highs at $X per ton in 2020, and then declined in the following year.

There were significant differences in the average prices amongst the major exporting countries. In 2021, amid the top suppliers, the country with the highest price was Romania ($X per ton), while Slovakia ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Romania (+12.5%), while the other leaders experienced a decline in the export price figures.

Medicaments Containing Insulin Imports

Imports in Eastern Europe

In 2021, approx. X tons of medicaments containing insulin but not antibiotics were imported in Eastern Europe; dropping by -75.6% against 2020 figures. Over the period under review, imports showed a dramatic curtailment. The most prominent rate of growth was recorded in 2016 when imports increased by 324% against the previous year. Over the period under review, imports hit record highs at X tons in 2013; however, from 2014 to 2021, imports remained at a lower figure.

In value terms, medicaments containing insulin imports fell sharply to $X in 2021. Overall, imports recorded a sharp curtailment. The most prominent rate of growth was recorded in 2016 with an increase of 298%. Over the period under review, imports attained the peak figure at $X in 2018; however, from 2019 to 2021, imports remained at a lower figure.

Imports by Country

Russia was the key importing country with an import of about X tons, which finished at 57% of total imports. It was distantly followed by Ukraine (X tons) and Belarus (X tons), together mixing up a 40% share of total imports. Slovakia (X kg) held a little share of total imports.

From 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the leading importing countries, was attained by Slovakia (with a CAGR of +43.0%), while imports for the other leaders experienced mixed trends in the imports figures.

In value terms, Russia ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in Eastern Europe, comprising 93% of total imports. The second position in the ranking was taken by Ukraine ($X), with a 3.9% share of total imports. It was followed by Slovakia, with a 1.5% share.

From 2012 to 2021, the average annual growth rate of value in Russia amounted to -27.6%. In the other countries, the average annual rates were as follows: Ukraine (-5.8% per year) and Slovakia (+49.9% per year).

Import Prices by Country

The import price in Eastern Europe stood at $X per ton in 2021, picking up by 46% against the previous year. Overall, the import price showed strong growth. The growth pace was the most rapid in 2014 when the import price increased by 65%. Over the period under review, import prices hit record highs in 2021 and is likely to continue growth in the near future.

There were significant differences in the average prices amongst the major importing countries. In 2021, amid the top importers, the country with the highest price was Russia ($X per ton), while Belarus ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Russia (+24.4%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :